Beyond danger: Unmethylated CpG dinucleotides and the immunopathogenesis of disease

Immunology Letters

Volumn 73, Issue 1, 2000, Pages 13-18

  Goldberg, Billi ^a   Urnovitz, Howard B ^b   Stricker, Raphael B ^c  

^a Dinitrochlorobenzene Study Group   (United States)

^b Chronic Illness Research Foundation   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Alu; CpG; Gulf War Syndrome; HIV; Methylation

Indexed keywords

CYTIDINE PHOSPHATE; CYTIDINE PHOSPHATE GUANOSINE; DINUCLEOTIDE; UNCLASSIFIED DRUG;

DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; METHYLATION; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0034600745     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(00)00191-7     Document Type: Article

References (59)

1. Klinman D.M., Barnhart K.M., Conover J. CpG motifs as immune adjuvants. Vaccine. 17:1999;19-25.
2. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 15 (158):1997;3635-3639.
3. Tokunaga T., Yamamoto H., Shimada S., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72:1984;955-962.
4. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K., Wagner H. Bacterial DNA causes septic shock. Nature. 386:1997;336-337.
5. Sun S., Beard C., Jaenisch R., Jones P., Sprent J. Mitogenicity of DNA from different organisms for murine B cells. J. Immunol. 159:1997;3119-3125.
6. Shpaer E.G., Mullins J.I. Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression. Nucleic Acids Res. 18:1990;5793-5797.
7. Campbell A., Mrazek J., Karlin S. Genome signature comparisons among prokaryote, plasmid, and mitochondrial DNA. Proc. Natl. Acad. Sci. USA. 96:1999;9184-9189.
8. Karlin S., Doerfler W., Cardon L.R. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68:1994;2889-2897.
9. Bednarik D.P. The silencing of human immunodeficiency virus. Russo V.E.A., Martienssen R.A., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;547-559 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
10. Nyce J.W. CpG suppression in HIV-1 versus HIV-2: correlation with pathogenicity and possible implications for the design of antiretroviral vaccines. Russo V.E.A., Martienssen R.A., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;561-574 Cold Spring Harbor Laboratory Press, Spring Harbor, NY.
11. Chu R.S., Askew D., Noss E.H., Tobian A., Krieg A.M., Harding C.V. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 163:1999;1188-1194.
12. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:1999;2291-2298.
13. Krieg A.M., Yi A.K., Matson S., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
14. Redford T.W., Yi A.K., Ward C.T., Krieg A.M. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J. Immunol. 161:1998;3930-3935.
15. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
16. Wooldridge J.E., Ballas Z., Krieg A.M., Weiner G.J. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood. 89:1997;2994-2998.
17. Kimura Y., Sonehara K., Kuramoto E., et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. (Tokyo). 116:1994;991-994.
18. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147:1991;1759-1764.
19. Pisetsky D.S., Reich C. Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides. Mol. Biol. Rep. 18:1993;217-221.
20. Hacker H., Mischak H., Miethke T., et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:1998;6230-6240.
21. Yi A.K., Krieg A.M. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161:1998;4493-4497.
22. Jahns R., Boivin V., Siegmund C., Inselmann G., Lohse M.J., Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation. 99:1999;649-654.
23. Mann D.L. Inflammatory mediators in heart failure: homogeneity through heterogeneity. Lancet. 353:1999;1812-1813.
24. Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
25. Bachmaier K., Neu N., de la Maza L.M., Pal S., Hessel A., Penninger J.M. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 283:1999;1335-1339.
26. Krieg A.M. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15:1995;284-292.
27. Deng G.M., Nilsson I.M., Verdrengh M., Collins L.V., Tarkowski A. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5:1999;702-705.
28. Sato Y., Miyata M., Sato Y., Nishimaki T., Kochi H., Kasukawa R. CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro. J. Rheumatol. 26:1999;294-301.
29. Tokano Y., Morimoto S., Kaneko H., Amano H., Nozawa K., Takasaki Y., Hashimoto H. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1- and Th2-derived cytokines. Clin. Exp. Immunol. 116:1999;169-173.
30. Cowdery J.S., Chace J.H., Yi A.K., Krieg A.M. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 5 (156):1996;4570-4575.
31. Hazelzet J.A., Kornelisse R.F., van der Pouw Kraan T.C., et al. Interleukin 12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease. Cytokine. 9:1997;711-716.
32. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27:1997;1671-1679.
33. Schwartz D.A., Quinn T.J., Thorne P.S., Sayeed S., Yi A.K., Krieg A.M. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:1997;68-73.
34. Schwartz D.A., Wohlford-Lenane C.L., Quinn T.J., Krieg A.M. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J. Immunol. 163:1999;224-231.
35. Lapatschek M.S., Gilbert R.L., Wagner H., Miethke T. Activation of macrophages and B lymphocytes by an oligodeoxynucleotide derived from an acutely pathogenic simian immunodeficiency virus. Antisense Nucleic Acid Drug Dev. 8:1998;357-370.
36. Cantwell A.R. The Cancer Microbe. 1990;Aries Rising Press, Los Angeles.
37. Cantwell A.R., Kelso D.W. Microbial findings in cancers of the breast and in their metastases to the skin. Implications for etiology. J. Dermatol. Surg. Oncol. 7:1981;483-491.
38. Singal R., Ginder G.D. DNA methylation. Blood. 93:1999;4059-4070.
39. Beatty P.R., Krams S.M., Martinez O.M. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J. Immunol. 158:1997;4045-4051.
40. Bonnet M., Guinebretiere J.M., Kremmer E., Grunewald V., Behhamou E., Contesso G., et al. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91:1999;1376-1381.
41. Magrath I., Bhatia K. Breast cancer: a new Epstein-Barr virus-associated disease? J. Natl. Cancer Inst. 91:1999;1349-1350.
42. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:1997;335-340.
43. Kochanek S., Renz D., Doerfler W. DNA methylation in the Alu sequences of diploid and haploid primary human cells. EMBO J. 12:1993;1141-1151.
44. Cornacchia E., Golbus J., Maybaum J., Strahler J., Hanash S., Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140:1988;2197-2200.
45. Liu W.M., Maraia R.J., Rubin C.M., Schmid C.W. Alu transcripts: cytoplasmic localisation and regulation by DNA methylation. Nucleic Acids Res. 22:1994;1087-1095.
46. Urnovitz H.B., Tuite J.J., Higashida J.M., Murphy W.H. RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22q11.2. Clin. Diagn. Lab. Immunol. 6:1999;330-335.
47. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity. 5:1996;303-310.
48. Rook G.A.W., Zumia A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet. 349:1997;1831-1833.
49. Calabretta B., Robberson D.L., Maizel A.L., Saunders G.F. mRNA in human cells contains sequences complementary to the Alu family of repeated DNA. Proc. Natl. Acad. Sci. USA. 78:1981;6003-6007.
50. Cheng J.Y., Meng C.L., Chao C.F., Gau S.D., Lin J.C. Human papillomavirus 16 DNA in NIH3T3 cells transformed by colonic cancer cellular DNA. Gut. 34:1993;1710-1713.
51. Jang K.L., Collins M.K., Latchman D.S. The human immunodeficiency virus tat protein increases the transcription of human Alu repeated sequences by increasing the activity of the cellular transcription factor TFIIIC. JAIDS. 5:1992;1142-1147.
52. Koga Y., Lindstrom E., Fenyo E.M., Wigzell H., Mak T.W. High levels of heterodisperse RNAs accumulate in T cells infected with human immunodeficiency virus and in normal thymocytes. Proc. Natl. Acad. Sci. USA. 85:1988;4521-4525.
53. Li J.Z., Steinman C.R. Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum. 32:1989;726-733.
54. Liu W.M., Chu W.M., Choudary P.V., Schmid C.W. Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res. 23:1995;1758-1765.
55. Sinnett D., Richer C., Deragon J.M., Labuda D. Alu RNA transcripts in human embryonal carcinoma cells. Model of post-transcriptional selection of master sequences. J. Mol. Biol. 226:1992;689-706.
56. Hooper L.V., Bry L., Falk P.G., Gordon J.I. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays. 20:1998;336-343.
57. Crooks P.A., Tribe M.J., Pinney R.J. Inhibition of bacterial DNA cytosine-5-methyltransferase by S-adenosyl-L-homocysteine and some related compounds. J. Pharm. Pharmacol. 36:1984;85-89.
58. Shatrov V.A., Ameyar M., Cai Z., Bettaieb A., Chouaib S. Methyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathway. Eur. Cytokine Netw. 10:1999;247-252.
59. Stricker R.B., Goldberg B., Epstein W.L. Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease. Immunol. Lett. 59:1997;145-150.